BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 12721360)

  • 1. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist.
    Nakae S; Saijo S; Horai R; Sudo K; Mori S; Iwakura Y
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5986-90. PubMed ID: 12721360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Horai R; Nakajima A; Habiro K; Kotani M; Nakae S; Matsuki T; Nambu A; Saijo S; Kotaki H; Sudo K; Okahara A; Tanioka H; Ikuse T; Ishii N; Schwartzberg PL; Abe R; Iwakura Y
    J Clin Invest; 2004 Dec; 114(11):1603-11. PubMed ID: 15578092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD28-dependent differentiation into the effector/memory phenotype is essential for induction of arthritis in interleukin-1 receptor antagonist-deficient mice.
    Kotani M; Hirata K; Ogawa S; Habiro K; Ishida Y; Tanuma S; Horai R; Iwakura Y; Kishimoto H; Abe R
    Arthritis Rheum; 2006 Feb; 54(2):473-81. PubMed ID: 16453283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
    Zhou F; He X; Iwakura Y; Horai R; Stuart JM
    Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of tumor necrosis factor-alpha in the development of T cell-dependent aortitis in interleukin-1 receptor antagonist-deficient mice.
    Matsuki T; Isoda K; Horai R; Nakajima A; Aizawa Y; Suzuki K; Ohsuzu F; Iwakura Y
    Circulation; 2005 Aug; 112(9):1323-31. PubMed ID: 16129814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulatory effects of allogeneic mixed chimerism induced by nonmyeloablative bone marrow transplantation on chronic inflammatory arthritis and autoimmunity in interleukin-1 receptor antagonist-deficient mice.
    Cho SG; Min SY; Park MJ; Lee KW; Cho YG; Cho ML; Chang HS; Park SH; Lee JW; Min WS; Kim CC; Kim HY
    Arthritis Rheum; 2006 Jun; 54(6):1878-87. PubMed ID: 16736524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice.
    Koenders MI; Devesa I; Marijnissen RJ; Abdollahi-Roodsaz S; Boots AM; Walgreen B; di Padova FE; Nicklin MJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2008 Nov; 58(11):3461-70. PubMed ID: 18975337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
    Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY
    Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
    Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
    Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell dependence of chronic destructive murine arthritis induced by repeated local activation of Toll-like receptor-driven pathways: crucial role of both interleukin-1beta and interleukin-17.
    Joosten LA; Abdollahi-Roodsaz S; Heuvelmans-Jacobs M; Helsen MM; van den Bersselaar LA; Oppers-Walgreen B; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Jan; 58(1):98-108. PubMed ID: 18163514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.
    Hirota K; Hashimoto M; Yoshitomi H; Tanaka S; Nomura T; Yamaguchi T; Iwakura Y; Sakaguchi N; Sakaguchi S
    J Exp Med; 2007 Jan; 204(1):41-7. PubMed ID: 17227914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
    Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
    J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF, but not IL-6 and IL-17, is crucial for the development of T cell-independent psoriasis-like dermatitis in Il1rn-/- mice.
    Nakajima A; Matsuki T; Komine M; Asahina A; Horai R; Nakae S; Ishigame H; Kakuta S; Saijo S; Iwakura Y
    J Immunol; 2010 Aug; 185(3):1887-93. PubMed ID: 20610641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL; Joosten LA; Arntz OJ; Bennink MB; Takahashi N; Carlsen H; Martin MU; van den Berg WB; van de Loo FA
    Arthritis Rheum; 2005 Jul; 52(7):2202-11. PubMed ID: 15986350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses.
    Nambu A; Nakae S; Iwakura Y
    Int Immunol; 2006 May; 18(5):701-12. PubMed ID: 16569679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models.
    Iwakura Y
    Cytokine Growth Factor Rev; 2002; 13(4-5):341-55. PubMed ID: 12220548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice.
    Cho ML; Kang JW; Moon YM; Nam HJ; Jhun JY; Heo SB; Jin HT; Min SY; Ju JH; Park KS; Cho YG; Yoon CH; Park SH; Sung YC; Kim HY
    J Immunol; 2006 May; 176(9):5652-61. PubMed ID: 16622035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice.
    Kagari T; Tanaka D; Doi H; Iwakura Y; Shimozato T
    Eur J Immunol; 2007 Oct; 37(10):2753-63. PubMed ID: 17823985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
    Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
    Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.